![]() |
市場調查報告書
商品編碼
1880393
單切口腹腔鏡手術器械市場預測至2032年:按產品類型、應用、最終用戶和地區分類的全球分析Single-Port Laparoscopic Surgery Devices Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球單切口腹腔鏡手術器械市場價值將達到 9.224 億美元,到 2032 年將達到 18.6726 億美元,預測期內複合年成長率為 10.6%。
單孔腹腔鏡手術器械是一種先進的微創手術設備,只需在腹部(通常位於肚臍附近)做一個小切口即可完成手術。它們整合了成像系統、通路和多功能器械,使外科醫生能夠在腹腔內有效地進行操作。單孔設計可減少創傷、疼痛和疤痕,並加速術後恢復,使外科醫生能夠以可控且高效的方式完成複雜的手術。
慢性病發生率呈上升趨勢
醫療機構正擴大採用微創方法,例如單孔腹腔鏡手術(SPLS),以微創方式治療複雜的疾病。診斷影像技術的進步和早期檢測的普及擴大了適合手術的患者群體。已開發國家和新興國家人口老化進一步加劇了對高效手術設備的需求。機器人輔助的單孔腹腔鏡手術系統提高了手術精度,減少了併發症,並縮短了恢復時間。個人化醫療的趨勢也在推動針對患者獨特需求而客製化的專用腹腔鏡器械的問世。
缺乏標準化程序和數據
不同醫院和地區間技術水平的差異導致患者治療效果不一致。缺乏單孔腹腔鏡手術的全面長期數據,導致臨床應用和醫保核准延遲。外科醫生培訓要求仍然很高,增加了操作複雜性,限制了擴充性。小規模醫療設備製造商在缺乏可靠的臨床證據或標準化指南的情況下,難以建立信譽。這些因素共同阻礙了單孔腹腔鏡手術技術的市場滲透,並減緩了創新步伐。
擴充機器人輔助SPLS
與傳統腹腔鏡器械相比,先進的機器人系統具有更高的操控性、更佳的視野和更精準的操作。醫院正日益增加對機器人輔助單孔腹腔鏡手術(SPLS)的投資,以改善手術效果並縮短手術時間。將機器人技術與單孔入路結合,可最大限度地減少疤痕並加快患者康復。隨著醫療基礎設施的現代化和手術量的成長,新興市場正擴大採用機器人輔助SPLS。機器人技術、人工智慧和診斷成像技術的持續研發可望大幅拓展SPLS的應用範圍。
其他微創手術技術
單孔腹腔鏡手術(SPLS)面臨其他微創手術方式的競爭,例如多孔腹腔鏡手術和經自然腔道內視鏡手術(NOTES)。這些替代技術通常被認為更為成熟,並擁有充足的臨床數據來支持其應用。如果現有技術已取得令人滿意的結果,醫院可能不願意投資SPLS設備。成本也是一個考慮因素,因為SPLS系統的實施成本可能更高。患者的偏好以及外科醫生對傳統腹腔鏡手術的熟悉程度也進一步限制了SPLS的廣泛應用。
疫情擾亂了全球外科手術的正常進行,導致擇期手術推遲,對單點雷射手術(SPLS)設備的需求下降。生產和供應鏈的中斷造成了關鍵手術設備的短缺。然而,這場危機加速了數位化進程,醫院開始探索遠端手術平台和遠距離診斷。緊急監管核準確保了即使在尖峰時段,也能獲得必要的手術工具。後疫情時代的策略強調韌性、自動化和分散式生產,以應對未來的衝擊。
預計在預測期內,普通外科手術將佔據最大的市場佔有率。
由於其在盲腸切除手術、疝氣修補術和膽囊切除術等多種手術中的應用,普通外科領域的需求穩定,預計在預測期內將佔據最大的市場佔有率。單點雷射輔助裝置(SPLS)因其減少疤痕和加快恢復時間,在一般外科手術中越來越受歡迎。醫院正擴大採用先進的器械來提高效率並最大限度地降低手術風險。全球手術量的成長進一步鞏固了SPLS在一般外科手術中的重要性。器械設計和人體工學方面的持續創新進一步強化了主導地位。
預計在預測期內,門診手術中心(ASC)細分市場將呈現最高的複合年成長率。
預計在預測期內,門診手術中心(ASC)領域將實現最高成長率,因為其經濟高效的模式和較短的患者周轉時間使其成為微創手術的理想場所。門診手術中心正擴大採用先進的單點雷射手術(SPLS)設備,從而能夠在傳統醫院之外進行複雜的手術。優惠的報銷政策鼓勵患者和醫療服務提供者轉向門診治療。雲端基礎的監控和庫存管理系統正在提高這些中心的營運效率。
預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家醫療基礎設施的快速擴張正在推動市場需求。各國政府正大力投資醫院現代化和醫療設備製造。本地化生產措施和進口替代政策也為市場成長提供了支持。機器人輔助單點定位系統(SPLS)和人工智慧驅動的診斷技術在全部區域的應用正在加速。全球製造商與區域公司之間的策略合作正在促進技術轉移和市場滲透。
預計北美地區在預測期內將呈現最高的複合年成長率。美國和加拿大在手術機器人、智慧手術室和人工智慧診斷技術方面處於主導地位。簡化的監管流程正在促進下一代單點雷射手術系統(SPLS)工具的快速商業化。醫院正在整合物聯網和分析技術,以最佳化手術流程並改善患者預後。健全的報銷機制正在支持微創技術的廣泛應用。
According to Stratistics MRC, the Global Single-Port Laparoscopic Surgery Devices Market is accounted for $922.40 million in 2025 and is expected to reach $1867.26 million by 2032 growing at a CAGR of 10.6% during the forecast period. Single-port laparoscopic surgery devices are advanced tools used to conduct minimally invasive surgeries through one small incision, usually near the belly button. They combine imaging systems, access channels, and versatile instruments to allow surgeons to maneuver and operate inside the abdomen effectively. Their single-entry design reduces trauma, lowers pain and scarring, and supports faster healing, offering surgeons a controlled and streamlined way to perform complex procedures.
Increasing prevalence of chronic diseases
Healthcare providers are increasingly turning to minimally invasive approaches like SPLS to manage complex conditions with reduced trauma. Improvements in diagnostic imaging and early detection are expanding the pool of patients eligible for surgical interventions. Aging populations across both developed and emerging economies are further accelerating the need for efficient surgical devices. Robotic-assisted SPLS systems are enhancing precision, reducing complications, and shortening recovery times. The broader trend toward personalized medicine is also encouraging adoption of specialized laparoscopic instruments tailored to patient-specific needs.
Limited procedure standardization and data
Variability in techniques across hospitals and regions creates inconsistencies in patient outcomes. The lack of comprehensive long-term data on SPLS procedures slows clinical adoption and reimbursement approvals. Training requirements for surgeons remain high, adding to operational complexity and limiting scalability. Smaller device manufacturers struggle to establish credibility without robust clinical evidence and standardized guidelines. These factors collectively hinder rapid market penetration and slow the pace of innovation in SPLS technologies.
Robotic-assisted SPLS expansion
Advanced robotic systems provide enhanced dexterity, visualization, and precision compared to conventional laparoscopic tools. Hospitals are increasingly investing in robotic-assisted SPLS to improve surgical outcomes and reduce operative times. The combination of robotics and single-port access minimizes scarring and accelerates patient recovery. Emerging markets are adopting robotic SPLS as healthcare infrastructure modernizes and surgical volumes rise. Continuous R&D in robotics, AI, and imaging is expected to significantly expand the scope of SPLS applications.
Alternative minimally invasive techniques
The SPLS faces competition from other minimally invasive approaches such as multi-port laparoscopy and natural orifice transluminal endoscopic surgery (NOTES). These alternatives are often perceived as more established, with broader clinical data supporting their use. Hospitals may hesitate to invest in SPLS devices when existing techniques already deliver satisfactory outcomes. Cost considerations also play a role, as SPLS systems can be more expensive to implement. Patient preference and surgeon familiarity with traditional laparoscopic methods further limit SPLS adoption.
The pandemic disrupted surgical practices worldwide, delaying elective procedures and reducing demand for SPLS devices. Manufacturing and supply chain interruptions caused shortages in critical surgical equipment. However, the crisis accelerated digital adoption, with hospitals exploring tele-surgical platforms and remote diagnostics. Emergency regulatory approvals helped maintain access to essential surgical tools during peak disruption. Post-pandemic strategies now emphasize resilience, automation, and decentralized production to safeguard against future shocks.
The general surgery segment is expected to be the largest during the forecast period
The general surgery segment is expected to account for the largest market share during the forecast period, due to its broad application across procedures such as appendectomies, hernia repairs, and gallbladder removals drives consistent demand. SPLS devices are increasingly preferred in general surgery due to reduced scarring and faster recovery times. Hospitals are adopting advanced instruments to improve efficiency and minimize operative risks. Rising surgical volumes globally are reinforcing the importance of SPLS in general surgical practice. Continuous innovation in device design and ergonomics is further strengthening this segment's leadership.
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate, due to their cost-efficient models and shorter patient turnaround times make them ideal settings for minimally invasive procedures. ASCs are increasingly equipped with advanced SPLS tools, enabling complex surgeries outside traditional hospitals. Favorable reimbursement policies are encouraging patients and providers to shift toward outpatient care. Cloud-based monitoring and inventory systems are enhancing operational efficiency in these centers.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapidly expanding healthcare infrastructure in countries like China, India, and Japan is fueling demand. Governments are investing heavily in hospital modernization and medical device manufacturing. Local production initiatives and import substitution policies are supporting market growth. Adoption of robotic-assisted SPLS and AI-driven diagnostics is accelerating across the region. Strategic collaborations between global manufacturers and regional players are strengthening technology transfer and market penetration.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The U.S. and Canada are leading in surgical robotics, smart operating rooms, and AI-enabled diagnostics. Streamlined regulatory pathways are encouraging faster commercialization of next-generation SPLS tools. Hospitals are integrating IoT and analytics to optimize surgical workflows and improve patient outcomes. Strong reimbursement frameworks support widespread adoption of minimally invasive technologies.
Key players in the market
Some of the key players in Single-Port Laparoscopic Surgery Devices Market include Medtronic, Intuitive Surgical, Johnson & Johnson, Olympus Corporation, Karl Storz, Stryker Corporation, Applied Medical, CONMED Corporation, Vicarious Surgical, Titan Medical, Advanced Surgical Concepts, NewView Surgical, Unimax Medical Systems, Sejong Medical, and Zhejiang Geyi Medical.
In October 2025, Johnson & Johnson MedTech announced the U.S. launch of INHANCE INTACT(TM), a proprietary complete instrumentation system specifically developed for subscapularis-sparing total shoulder arthroplasty1 (TSA), empowering surgeons to replace a damaged shoulder joint while keeping the shoulder muscle intact.
In October 2025, Olympus Corporation has entered into an international distribution agreement with the medical products business of U.S.-based W. L. Gore & Associates, Inc., a global materials science company that develops innovative products across diverse industries. The agreement allows Olympus to become the exclusive international distributor and have distribution rights of the GORE(R) VIABIL(R) Biliary Endoprosthesis for endoscopic placement.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.